Recent Updates in the Treatment of CML

Insights from 2023 ASH Annual Meeting
E

ASH 2023 Insights: "Treatment Patterns & Clinical Outcomes Among Patients With CML-CP Treated With Asciminib in US Clinical Practice"

By Insights from 2023 ASH Annual Meeting FEATURING Ehab Atallah
By Insights from 2023 ASH Annual Meeting FEATURING Ehab Atallah
635 views
December 22, 2023
Comments 0
Login to view comments. Click here to Login
06:26

Managing TKI AEs in CML: Thrombocytopenia, Hypertension, Pancreatic …

Akriti Jain

90 views
17:47

Treating CML Patients With TKI Resistance vs. TKI Intolerance

The University of Alabama at Birmingham School of Medicine

O. Jamy

297 views
18:55

iCMLf Conversations: CML Clinical Highlights of EHA 2023

International CML Foundation

A. Hochhaus

155 views
17:30

SOHO 2023: Rational TKI Choice in CML

SOHO 2023 Eleventh Annual Meeting

M. Deininger

309 views
16:25

SOHO 2023: The New ELN Laboratory Recommendations for the Diagnosis …

SOHO 2023 Eleventh Annual Meeting

N. Cross

430 views
06:15

Unmet Needs in CML: Patient & Physician Perspectives From the CML SU…

Jorge Cortés

82 views
04:16

Efficacy and Safety of Asciminib in Ph+ CML

Luke Fletcher

948 views
11:02

ASH 2023 Insights: "Asciminib Combined With Dasatinib and Prednisone…

Dana-Farber Cancer Institute

M. Luskin

208 views
08:32

ASH 2023 Insights: "ALLG CML13 ASCEND-CML Study - Asciminib Treatmen…

Insights from 2023 ASH Annual Meeting

D. Yeung

125 views